Abstracts - faqs.org

Abstracts

Business, international

Search abstracts:
Abstracts » Business, international

ICN's Yogoslav subsidiary is seized by Serbian police

Article Abstract:

The Serbian government has seized control of the Yugoslav unit of ICN Pharmaceuticals. Police and government officials forcibly entered the Belgrade plant and over protest of the workers took possession of the premises. Milan Panic, chairman and CEO of the company called the takeover "theft of a grand order." Health Minsister, Leposava Millicevic, claimed that the move was the result of ICN paying only $50million of the $270 million agreed upon for ICN to take control of 75% of the Belgrade plant from the Yugoslav Government. Mr. Panic will pursue his claim against the government vigorously.

Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 1999
Acquisitions & mergers, Mergers, acquisitions and divestments, Advertorial

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Six ICN managers are arrested after Serbian forces seize unit

Article Abstract:

Authorities in Serbia arrested six leading managers of ICN Pharmaceuticals Inc. two days after they seized ICN's subsidiary, ICN Belgrade. Six local managers, along with ICN Belgrade's general counsel, were arrested by police. Serbia asserts that ICN is guilty of underpaying the country in a 1991 contract to acquire 75% of the Galenika company. Serbian government officials appointed its deputy health minister, Marija Krstajic, as the subsidiary's acting director.

Comment:

Authorities in Serbia arrest six leading managers of ICN Pharmaceuticals

Author: Reed, John (American senator)
Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 1999
Crimes against

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Merck will build a second plant in Singapore

Article Abstract:

Merck and Co. will construct a second pharmaceutical plant in Singapore. The new plant will increase the company's investments in Singapore to over US$500 million (552 million euros).

Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2001
New capacity, new plant construction, Singapore, Buildings and facilities, Merck & Company Inc.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Pharmaceutical industry, Drugs, Abstract, Yugoslavia, ICN, Valeant Pharmaceuticals International
Similar abstracts:
  • Abstracts: Exploring strategies for companies that use manufacturers' representatives as their sales force. A conceptual model for building and maintaining relationships between manufactures' representatives and their principals
  • Abstracts: Chery assembly deal makes Chrysler a model in exporting from China. Could Czech smokers help balance budget?
  • Abstracts: Case study of statistically estimating minimum makespan for flow line in scheduling problems
  • Abstracts: Decision support for risk analysis in energy policy. Analysing AHP-matrices by regression. Behavioral and procedural consequences of structural variation in value trees
  • Abstracts: Plane sense: airlines. Managing the future: American Airlines
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.